Gastric Cancer

• CLINICAL_TRIALS trial_result · 2020-09-18
  Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

  Phase 2 trial evaluating andecaliximab with nivolumab vs nivolumab alone in unresectable or recurrent gastric or gastroesophageal junction a…

• CLINICAL_TRIALS trial_result · 2020-09-18
  Clinical Trial Update: Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy [Phase 2]

  Phase 2 study update for KH903 in advanced gastric or gastroesophageal junction adenocarcinoma as second-line therapy; status not disclosed.

• CLINICAL_TRIALS trial_result · 2020-08-24
  Clinical Trial Update: Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer [Phase 2]

  Clinical trial update for pegyliposomal doxorubicin and 5-fluorouracil as second-line therapy in metastatic gastric cancer (Phase 2).

• CLINICAL_TRIALS trial_result · 2020-08-03
  Clinical Trial Update: Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer [Phase 3]

  Phase 3 trial evaluating vaccine therapy in combination with chemotherapy for metastatic or locally recurrent stomach and esophageal cancers…

• CLINICAL_TRIALS trial_result · 2020-08-03
  Clinical Trial Update: Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach [Phase 2]

  Phase 2 clinical trial evaluating irinotecan and paclitaxel in metastatic or recurrent esophageal or gastric cancer has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-08-03
  Clinical Trial Update: Irinotecan in Treating Patients With Esophageal or Stomach Cancer [Phase 2]

  Phase 2 clinical trial investigating irinotecan in esophageal and gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-07-23
  Clinical Trial Update: Tisseel® as a Reinforcement of Esophagojejunal Anastomoses [Phase 4]

  Phase 4 clinical trial evaluating Tisseel as reinforcement of esophagojejunal anastomoses in gastric cancer patients to reduce anastomotic l…

• CLINICAL_TRIALS trial_result · 2020-06-22
  Clinical Trial Update: Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer [Phase 2]

  Phase 2 trial Dragon III compares neoadjuvant FLOT versus SOX in gastric cancer; results were posted after completion.

• CLINICAL_TRIALS trial_result · 2020-06-17
  Clinical Trial Update: A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. [Phase 2, Phase 3]

  A clinical trial comparing QL1604 plus nab-paclitaxel versus nab-paclitaxel alone in advanced gastric or gastroesophageal junction adenocarc…

• CLINICAL_TRIALS trial_result · 2020-06-05
  Clinical Trial Update: Gastric Tissue Stapler Comparison Study

  A completed clinical trial comparing gastric tissue staplers in gastric resection procedures; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2020-06-01
  Clinical Trial Update: Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) [Phase 1, Phase 2]

  A clinical trial update for neoadjuvant chemotherapy with PISOXO in locally invaded gastric cancer spanning Phase 1 and Phase 2.

• CLINICAL_TRIALS trial_result · 2020-05-22
  Clinical Trial Update: The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy [Phase 3]

  Phase 3 clinical trial evaluating how an Enhanced Recovery After Surgery (ERAS) program affects clinical and immunological outcomes after mi…

• CLINICAL_TRIALS trial_result · 2020-05-15
  Clinical Trial Update: FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer [Phase 2]

  A Phase 2 trial evaluating FOLFOX plus regorafenib in unresectable or metastatic esophagogastric cancer has completed with results posted in…

• CLINICAL_TRIALS trial_result · 2020-05-13
  Clinical Trial Update: A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma [Phase 3]

  Phase 3 study evaluating anlotinib hydrochloride capsule with AK105 in advanced gastric and gastro-oesophageal junction adenocarcinoma is in…

• CLINICAL_TRIALS trial_result · 2020-05-11
  Clinical Trial Update: A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma [Phase 1, Phase 2]

  A Phase 1b/2 trial evaluating MEDI4736 (durvalumab) with tremelimumab, MEDI4736 alone, or tremelimumab alone in gastric or gastroesophageal …

• CLINICAL_TRIALS trial_result · 2020-05-07
  Clinical Trial Update: A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers [Phase 1]

  A Phase 1 pilot study evaluating the safety and feasibility of adding FOLFIRINOX chemotherapy to neoadjuvant radiation for gastric and gastr…

• CLINICAL_TRIALS trial_result · 2020-04-29
  Clinical Trial Update: Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer [Phase 2]

  Phase 2 trial evaluating perioperative chemotherapy plus PD-1 antibody for gastric cancer; efficacy and safety data not yet reported in the …

• CLINICAL_TRIALS trial_result · 2020-04-20
  Clinical Trial Update: Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection [Phase 3]

  Phase 3 trial evaluating capecitabine versus observation after R0 resection in certain gastric cancer patients.

• CLINICAL_TRIALS trial_result · 2020-04-20
  Clinical Trial Update: A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer [Phase 2]

  Phase 2 study evaluating camrelizumab in combination with docetaxel and S-1 as adjuvant therapy for stage III gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-04-14
  Clinical Trial Update: Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer [Phase 2]

  A Phase 2 clinical trial update evaluating camrelizumab plus apatinib and tegio in first-line refractory patients with advanced gastric canc…

• CLINICAL_TRIALS trial_result · 2020-04-14
  Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update on hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-03-25
  Clinical Trial Update: Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial [Phase 3]

  Phase III randomized trial evaluating adjuvant chemotherapy with S-1 versus S-1/Oxaliplatin with or without radiotherapy for completely rese…

• CLINICAL_TRIALS trial_result · 2020-03-24
  Clinical Trial Update: Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial evaluating radical gastrectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced gastric ca…

• CLINICAL_TRIALS trial_result · 2020-03-23
  Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer [Phase 3]

  Phase 3 trial updating adjuvant chemotherapy with Nab-paclitaxel plus S-1 for stage III gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-03-20
  Clinical Trial Update: mFLOT Chemotherapy as First-line Treatment in GC [Phase 1, Phase 2]

  Clinical trial update on mFLOT chemotherapy as first-line treatment for gastric cancer, including Phase 1 and Phase 2 results.